miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway
Sheng LiuDepartment of Urology, Chongqing Three Gorges Central Hospital, Chongqing, People’s Republic of ChinaQin WangDepartment of Oncology, Chongqing Three Gorges Central Hospital, Chongqing, People’s Republic of ChinaYin LiuDepartment of Urology, Chongqing Three Gorges Central Hospital, Chongqing, People’s Republic of ChinaZongyu XiaDepartment of Urology, Chongqing Three Gorges Central Hospital, Chongqing, People’s Republic of China
2019en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references